{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/1b454f3a-002e-540e-82a0-3e5bcb0b5da9/695ebbc2313b808065d746a3?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"The genetics of cannabis lifetime use","description":"<p>Cannabis, which is increasingly legally available, both for therapeutic and recreational use, is now one of the most commonly used drugs worldwide.&nbsp;Of people who have ever used cannabis, studies vary, but they estimate that about 10-25 percent of people who use cannabis go on to develop cannabis use disorder.</p><p><br></p><p>Uri Bright is a postdoctoral associate at the Yale School of Medicine and is one of the authors of a recent study in the journal Neuropsychopharmacology on the genetics of cannabis lifetime use — which is anyone who has ever used cannabis even once. That’s a distinct population from people who have cannabis use disorder, as his colleagues had looked into in the previous study.</p>","author_name":"Springer Nature"}